Atlas Trials

Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B

Clinical trial NCT04069858 · UNKNOWN

Trial details

NCT number
NCT04069858
Sponsor
Korea University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2016-12-01
Primary completion
2019-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.